Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Small Plaque Psoriasis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT05335356
What this trial is testing

Comparing Efficacy and Safety of Bmab 1200 and Stelara in Patients With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Moderate to Severe Chronic Plaque Psoriasis
Biocon Biologics UK Ltd 384
Testing effectiveness (Phase 2)Study completedNCT00646191
What this trial is testing

Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Abbott 137
Testing effectiveness (Phase 2)Active Not RecruitingNCT07623486
What this trial is testing

Trial of HSK44459 Cream for the Management Plaque Psoriasis

Who this might be right for
Psoriasis
Haisco Pharmaceutical Group Co., Ltd. 180
Testing effectiveness (Phase 2)Study completedNCT02432040
What this trial is testing

Efficacy of Atorvastatin as Adjunctive Treatment for Chronic Plaque Type Psoriasis

Who this might be right for
Psoriasis
Philippine Dermatological Society 28
Testing effectiveness (Phase 2)Study completedNCT01001468
What this trial is testing

Study to Assess VB-201 in Patients With Psoriasis

Who this might be right for
Active Plaque Psoriasis
Vascular Biogenics Ltd. operating as VBL Therapeutics 185
Not applicableNot Yet RecruitingNCT06802848
What this trial is testing

Real-World Study of Xeligekimab for Moderate to Severe Plaque Psoriasis(XP-Real)

Who this might be right for
Plaque PsoriasisPsoriatic ArthritisScalp Psoriasis+3 more
Chongqing Genrix Biopharmaceutical Co., Ltd 1,000
Large-scale testing (Phase 3)Study completedNCT03875508
What this trial is testing

Assess Usability of Risankizumab Autoinjector Combination Product in Participants With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
AbbVie 108
Testing effectiveness (Phase 2)Study completedNCT02564042
What this trial is testing

A Dose-Finding Study of GSK2894512 Cream in Subjects With Plaque Psoriasis

Who this might be right for
Psoriasis
GlaxoSmithKline 227
Not applicableUnknownNCT04722094
What this trial is testing

Prevalence of Periodontitis in Patients With Plaque Psoriasis. A Cross-sectional Study

Who this might be right for
PsoriasisPlaque PsoriasisPeriodontal Diseases+1 more
University of Siena 147
Testing effectiveness (Phase 2)Study completedNCT06972888
What this trial is testing

A Phase II Clinical Study of AC-201 Tablets in Subjects With Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Accro Bioscience (Suzhou) Limited 145
Large-scale testing (Phase 3)Study completedNCT01970488
What this trial is testing

Study to Compare Efficacy and Safety of ABP 501 and Adalimumab (HUMIRA®) in Adults With Moderate to Severe Plaque Psoriasis

Who this might be right for
Psoriasis
Amgen 350
Not applicableStudy completedNCT03236870
What this trial is testing

Evaluate the Effectiveness and Patient-Reported Outcome of Adalimumab in Patients With Moderate to Severe Plaque Psoriasis in China

Who this might be right for
Psoriasis
AbbVie 181
Not applicableLooking for participantsNCT07532486
What this trial is testing

Evaluate Comparative Efficacy and Safety of Guselkumab in High-dose and Extended-interval Versus Standard-dose in Chinese Participants of Moderate-to-severe Plaque Psoriasis

Who this might be right for
Psoriasis
Second Affiliated Hospital, Zhejiang University, School of Medicine 400
Post-approval studies (Phase 4)Study completedNCT01059773
What this trial is testing

A Safety and Efficacy Study of Ustekinumab in Patients With Plaque Psoriasis Who Have Had an Inadequate Response to Methotrexate

Who this might be right for
Psoriasis
Janssen-Cilag International NV 490
Not applicableStudy completedNCT02713295
What this trial is testing

Provide Real-world Evidence on the Treatment Goal Achievement Rate, Adherence to and Utilization Patterns of Adalimumab in Patients With Moderate to Severe Plaque Psoriasis in Greece

Who this might be right for
Moderate to Severe Plaque Psoriasis
AbbVie 273
Large-scale testing (Phase 3)Study completedNCT01597245
What this trial is testing

Study in Participants With Moderate to Severe Psoriasis (UNCOVER-2)

Who this might be right for
Psoriasis
Eli Lilly and Company 1,224
Large-scale testing (Phase 3)Study completedNCT01194219
What this trial is testing

Study to Evaluate Safety and Effectiveness of Oral Apremilast (CC-10004) in Patients With Moderate to Severe Plaque Psoriasis

Who this might be right for
Plaque Psoriasis
Amgen 844
Testing effectiveness (Phase 2)Study completedNCT01246583
What this trial is testing

CP-690-550 Ointment For Chronic Plaque Psoriasis

Who this might be right for
Psoriasis
Pfizer 71
Large-scale testing (Phase 3)Study completedNCT05108766
What this trial is testing

A Phase Ⅲ Study to Evaluate Tildrakizumab in the Treatment of Chinese Subjects With Moderate to Severe Plaquetype Psoriasis

Who this might be right for
Plaque Psoriasis
Shenzhen Kangzhe Pharmaceutical Co., Ltd. 220
Large-scale testing (Phase 3)Study completedNCT01722331
What this trial is testing

Evaluate the Efficacy and Safety of Subcutaneous MK-3222, Followed by an Optional Long-Term Safety Extension Study, in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-010)

Who this might be right for
Plaque Psoriasis
Sun Pharmaceutical Industries Limited 772
Next Page